Filter
166
Text search:
Anti-Tuberculosis
medicines
Featured
Recommendations
28
New Publications
54
Language
Document type
No document type
129
Guidelines
14
Studies & Reports
12
Manuals
6
Training Material
2
Situation Updates
2
Fact sheets
1
Countries / Regions
Western and Central Europe
9
Nepal
8
Eastern Europe
7
India
6
Zambia
6
Malawi
6
Ethiopia
5
Kenya
5
Uganda
4
South Africa
4
Namibia
4
Russia
4
Zimbabwe
3
Tanzania
3
Bangladesh
3
Myanmar / Burma
3
Nigeria
2
Rwanda
2
Asia
2
Burkina Faso
1
Liberia
1
Ghana
1
Pakistan
1
Afghanistan
1
Gambia
1
Mozambique
1
Eswatini/ Swaziland
1
Ukraine
1
Lesotho
1
Sri Lanka
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Latin America and the Carribbean
1
Bhutan
1
Poland
1
Timor Leste/ East Timor
1
Global
1
Authors & Publishers
Publication Years
Category
Countries
64
Clinical Guidelines
28
Public Health
5
Women & Child Health
5
Capacity Building
3
Key Resources
2
Pharmacy & Technologies
2
Toolboxes
TB
86
HIV
9
AMR
8
Pharmacy
6
Polio
4
Refugee
3
COVID-19
2
NTDs
2
Mental Health
1
Caregiver
1
6th edition, 2010. | Published in collaboration with World Health Organisation and Clinton Health Access Initiative.
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study
The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere
...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s
...
The objective of this book is to provide health workers with easily accessible information on important aspects of the medicines commonly used at primary care level in Zimbabwe. Medicines are a cruc
...
Lessons from the STEP-TB Project.
Accessed November 2017.
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and e
...
guidance for health managers, health workers, and activists
Accessed November 2017
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate
...
